Try our Advanced Search for more refined results
Life Sciences - April, 2023
354 articles
- GoodRx, Google, Meta Privacy Suits Get Consolidated In Calif.
- NY Firm To Arbitrate $124K Fee Spat With Malaysian Co.
- Woman Says Hip Implant Releases Toxic Metals In J&J Suit
- Philips Loses Trade Secret Trial While Getting DMCA Damages
- Juul 'Leadership Reset' Not Altria's Call, Bellwether Jury Told
- Masimo Jury Ends Week With Drama, No Verdict, 1 Less Juror
- SPAC Investor Sues In Del. Over Digital Platform Value Plunge
- Novartis Tells 2nd Circ. To Affirm Win In Kickback Suit
- Judge Gives Texas Blue Cross Win In $2M Unpaid Claim Suit
- Bradley Arant Hires IP Partners From Holland & Knight
- Nonprofit Attys, Dinsmore Seek Swift End To LabMD Suit
- Titan Of The Plaintiffs Bar: Keller Rohrback's Lynn Sarko
- Taxation With Representation: Latham, Shearman, Kirkland
- Short Message Data Challenges In E-Discovery
- Judge Recommends Win For 3M In N95 Price-Gouging Suit
- CEO Concedes Youth Vaping Hike After Altria Investment
- Reps. Tell Vidal She Is Overstepping With USPTO Power
- Dykema Brings On Ex-SDNY Prosecutor From Saul Ewing
- Dem Lawmakers Tell USPTO To Do More On Drug Patents
- Merck Says It Paid $573M To Settle Zetia Antitrust Case
- IP Forecast: Gov't To Face Off Against Gilead In Delaware
- EU Proposes New Rules Governing Essential Patent Rows
- McKinsey, Plaintiffs Spar Over Picking Opioid Bellwether Tribe
- Philips Fights Claims Based On 'Competition' With SoClean
- 6th Circ. Urged To Turn Down Call To Reconsider FCA Ruling
- Chancery Trims Suit Over $110M Bioness-Bioventus Deal
- 2 Firms Steer Quest's $450M Cancer Research Firm Buy
- What's Next After High Court Stay On Abortion Pill Ruling
- 5 Firms Guide Drug-Delivery Firm's $374M SPAC Merger
- Federal Legislators Reintroduce SAFE Cannabis Banking Bill
- Eli Lilly Unable To Sink $61M Award In Drug Rebate Case
- 11th Circ. Backs Teacher's Jury Win In Disability Bias Suit
- Judge Abused Discretion In Abortion Pill Order, 5th Circ. Told
- Monsanto Insider's Roundup Tune Got Rosier, Jury Hears
- Top Juul Investor Facilitated, Got $2.45B From Altria Deal
- Cannabis Co. Inks $3M Investor Deal To End SEC Probe Suit
- Holmes' Prison Date Delayed As 9th Circuit Considers Bail
- Del. Judge Nixes Moderna Bid To Toss COVID Vax Patent Suit
- Tracon's $200M Damages Claim Axed In Cancer Antibody Feud
- FTC's Khan Says Antitrust Laws Favor 'Building Over Buying'
- Mich. Judge OKs Hospital Class Deal Over Vax Mandates
- Boston Lab Company Sues Rival Over 'SmartLabs' TM
- Ambiguity In 'Buy America' Implementation May Slow Projects
- Orbital Snags $270M Series A Financing To Build Out RNA Biz
- PG&E, Elizabeth Holmes Prosecutor Joins Jones Day
- Thomas Report Is Final Straw — High Court Needs Ethics Code
- Chancery Preserves Walmart Opioid Suit, Citing Redactions
- Altria Knew Juul Targeted Youth Before Investing, Jury Told
- COVID-19 Test Maker Investors Seek Final OK For $8.1M Deal
- PTAB Guts Most Of Fla. Biotech Co.'s Heart Valve Patent
- Apple Expert Slices Into Masimo's $3.1B Damages Theory
- More AI, More Problems, Attorneys Tell Patent Office
- Talc Claimants Move To Toss J&J Unit's Ch. 11
- Senators Target PBMs In Deal On 4 Drug Pricing Bills
- Insys Founder Says US Attorney 'Misled' Prisons Bureau
- J&J Flags Selendy Gay Conflicts In Robot Surgery Tech Suit
- Medtronic Wants Rival's Surgical Market Antitrust Claims Axed
- Diaper Genie Makers Want False Ad Suit Tossed
- Horse Assoc. Loses Discovery Bid As Suit Races Toward Trial
- Ill. Dispensary Escapes Black Fired Worker's Race Bias Suit
- FTC Pauses Illumina-Grail Order Amid 5th Circ. Appeal
- 10 Considerations When Licensing AI For Drug Discovery
- CVS Reaches $3.8M Settlement In Suit Over Lidocaine Labels
- Teva Seeks Escape From Feds' MS Drug Kickback Suit
- 2 Firms Lead Assertio Buy Of Spectrum Pharma For $248M
- Joint Representation Ethics Lessons From Ga. Electors Case
- Purdue Pharma Gets OK To Sell Over-The-Counter Business
- Ex-Worker Denied Sanctions Against Biotech Co. In 401(k) Suit
- 9th Circ. Asked To Back Abstention Over Pot License Program
- Fed. Circ. Backs UK Pharma Firm's IP Win Against CBD Giant
- Opioid Judge Rips UnitedHealth's 'Insulting' Coercion Charge
- Altria Created 'Vaping Crisis,' Jurors Told At Trial Kickoff
- Apple Seeks $3B Trial Win, Calls Masimo Tech 'Bits And Bobs'
- Merck, Glenmark Cut Deal With Last Group Of Zetia Buyers
- Corp. Arbitration Without Attorneys Present Upheld On Appeal
- NJ Pot Co. Worker Says She Was Fired For Age, Gender
- Judge Consolidates CBP Supervisor's Vaccine Mandate Suits
- Boston Scientific Investors Seek Class Cert. In Stock Suit
- Texas Doctor Will Pay $8M To Settle False Claims Suit
- Feds Ask 10th Circ. To Rethink Tribal Reimbursement Case
- Fed. Circ. Won't Revive Microscope Co.'s Patent Challenge
- Aurinia Shareholder Urges Strategic Review, Company Sale
- 2 Firms Lead Artificial Heart Tech Maker's $480M SPAC Merger
- Lawyer Discernment Is Critical In The World Of AI
- Biotech Co., Insurer Drop $3.6M Frozen Meds Shipping Suit
- Hologic-Minerva Medical Device Fight Ends Without Fees
- Regeneron Bid For Prosecutor Docs Falls Short, Judge Says
- Lilly's Sale Of Diabetes Drug To Amphastar Could Exceed $1B
- Cannabis Considerations In Debt Collection, Credit Reporting
- Catching Up With Delaware's Chancery Court
- Exclusion Bars Subpoena Expenses Coverage, Judge Says
- Law360 Reveals Titans Of The Plaintiffs Bar
- Monsanto Can't Move Roundup Trials, Mo. High Court Hears
- Indian Pharma Co. Can't Revive Claim Over Xifaxan Royalties
- Celgene, BMS, Teva Can't Pause Cancer Drugs Antitrust Suit
- Seminal Kickback Rulings Mean 'You're Rarely In A Safe Zone'
- SEC Wants Pot Pill Co., Promoter's Fraud Suits Consolidated
- J&J Talc Claimants Form Committee To Support Ch. 11 Plan
- Supreme Court Preserves Abortion Pill Access, For Now
- Comparing 2 Approval Processes For Gene Therapies
- Philly-Area Medical Device Co. Pays $5.3M To End FCA Case
- House Bill Introduced To Allow Legal Pot Users To Buy Guns
- Medical Software Customers Want Data Breach Suits Joined
- Doc Who Risked $100M In Options Snared In COVID Fraud Net
- Fed. Circ. Won't Reconsider Reviving Bard Patents
- Senators Plot Sweeping Action On Pharmacy Intermediaries
- Merck, Glenmark Cut Deal With End Payors Before Zetia Trial
- Judge Rejects $15M Deal, Tells Atty 'I Don't Bargain With You'
- 9th Circ. Snuffs Out CBD Co.'s Appeal Of Tax Arbitration Order
- Don't Forget Alumni Engagement When Merging Law Firms
- Feds Say Justices Should Reject Appeal From Ex-Shkreli Atty
- Mallinckrodt Trust Can't Be Used To Pay Attys In Opioid MDL
- Attorney Conflict Dooms Arb. Win In Software Dispute
- Interstate Cannabis Commerce May Be In Reach, With Caveats
- DLA Piper Malpractice Suit Over Gummy Deal Dropped
- Monsanto Argues Citizenship Wasn't Needed For $413M Deal
- No J&J Talc Trials For 60 Days, Bankruptcy Judge Rules
- Senate Panel Advances 7 Judicial Picks, Delays Others
- UK Says $125M Hearing Implants Merger Could Hurt Patients
- NY Courts Say Vax Mandate Suit Is Been There, Done That
- Fed. Circ. Won't Let Sandoz Break Into Amgen's Otezla Market
- Altria Can't Bar School's 'Sparkly' Video From Vaping Trial
- Expert Challenges Aren't 'Helpful,' Flint Judge Tells VNA Attys
- Abortion Pill Maker Fights FDA To Protect Drug Approval
- Gilead, Janssen, Teva Can't Say HIV Drug Costs Passed On
- Calif. AG Defends New Weedkiller Cancer Warnings At 9th Circ.
- GNC Says 'Lean' Bars Are About Lifestyle, Not Fat Content
- HIV Drug Patients Fight Gilead's Bid To Toss Plaintiffs
- City of Dearborn Sues Trucking Company Over Dust Pollution
- Distributors Push 4th Circ. To Uphold Opioid Verdict
- Brooklyn Law Clinic Urges Justices To Review AI Inventorship
- 3M Respirator Suits Belong In Federal Court, 6th Circ. Says
- Inovio Investors Want 1st OK For COVID-19 Derivative Deal
- Feds Float Security Limits On Export Of Protein Synthesizers
- PTAB Upholds DNA Testing Patents Key To $272M Ravgen Win
- 5th Circ. Fast-Tracks Illumina's Grail Appeal
- Without Stronger Due Diligence, Attys Risk AML Regulation
- UMich Teacher's Discrimination Claims Sent To State Court
- Calif. Ruling May Sow Seeds Of Cannabis Patent Precedent
- Ore. Licenses First Psilocybin Therapy Facilitators
- Bracewell Adds Holland & Knight Health Pro In San Antonio
- Emory University's Ex-Legal Chief Joins Ropes & Gray In DC
- Alito Extends Freeze On Abortion Pill Rulings
- Bristol-Myers Unit Seeks To Revive Blood Thinner Patent
- 1st Circ. Says Jury Poll Gaffe In Civil Case Merits New Trial
- Landmark FCA Showdown Looking Like Defense Bar Letdown
- Elizabeth Holmes Fights 'Unjust' Conviction At 9th Circ.
- Abortion Pill Foes Tell Justices FDA 'Federalized Abortion'
- High Court Poised To Reject Objective FCA Scienter Rule
- Ga. Justices Consider Challenge To Opioid Litigation Law
- J&J Unit Knowingly Marketed Faulty Knee-Device, Suit Says
- Talc Claimants Attack Suit Injunction In J&J Unit's Ch. 11
- HHS Head Flouted Hatch Act, Investigation Finds
- Investors Settle Out Of SEC Insider Trading Suit, Fines TBD
- Aid To Illegal Drug Imports Kills Price Checker's Antitrust Suit
- W.Va. County Urges 4th Circ. To Revive Opioid Distributor Row
- Abortion Pill Rulings Will Hinder FDA Authority
- Red Cross Says Biotech's Antitrust Suit Makes No Sense
- 2 Firms Vie To Lead Investor Suit Over Co.'s COVID Claims
- Cannabis Labor Peace Laws Lay Fertile Ground For Unions
- 6th Circ. Mulls New CAFA Standard In 3M Respirator Suits
- Every Lawyer Can Act To Prevent Peer Suicide
- Covington To Open Boston Office With Life Sciences Focus
- Ex-NJ Firefighter Gets 3 Years For Role In $50M Drug Fraud
- Merck, Glenmark Settle With Direct Purchasers In Zetia Case
- 4 Firms Guide GSK's $2B Bellus Cough Drug Co. Takeover
- US Cos. Racked Up $96B In Price-Fixing Fines Since 2000
- Ex-FDA Officials, Legal Scholars Rip Abortion Pill Ruling
- Receiver Dropped From $7M Fertilizer Case Over Funding
- Illumina Latest To Settle Out Of DNA Testing Patent Dispute
- Purged Cutera Chair And CEO Sue 'Rogue' Board In Delaware
- What To Watch In Pay-For-Delay Trial Against Merck, Glenmark
- Justices Won't Review Sanofi's Antitrust Suit Over EpiPen
- House Bills Look To Guide Federal Cannabis Legalization
- Justices Won't Review Bar On New Calif. Prop 65 Suits
- Illumina Pushes FTC For Full Pause Of Grail Order
- Catching Up With Delaware's Chancery Court
- 4 Firms Will Seek Up To $21M For Bioverativ Suit Settlement
- Justices Won't Take Up Novartis-HEC Feud Over MS Drug
- Building On Successful Judicial Assignment Reform In Texas
- Ropes & Gray Adds Career Shearman Atty In NY
- Juul, Minn. AG Ink Deal After Close Of Trial
- LivaNova Sued For €21M Over Soured Heart Biz Acquisition
- Paul Weiss, Latham Drive Merck's $10.8B Calif. Biotech Buy
- FCA Bar Jittery As 'Game-Changing Case' Goes To Justices
- Ex-Insys Directors Agree To $175M Ch. 11 Settlement
- The Sidley Atty Battling FCA Scienter Standard At High Court
- Importer Seeks To Clear Incontinence Underpants Of Tariffs
- The History-Making Atty In A Historic FCA High Court Fight
- Deposition Do-Over Ordered In Diabetes Strip Fraud Suit
- SPACs Set Sights On Public Co. Targets Amid Market Distress
- How Lip Implant Ruling Has Affected Design Patent Disputes
- Medtronic Seeks New Patent Trial After $106.5M Verdict
- Shkreli Keeps Fighting 'Needlessly Crushing' Penalties
- 9th Circ. Upholds Health Care Co.'s Win In TCPA Suit
- Feds, Wash. Fight Red States' Bid To Join Abortion Pill Suit
- DOJ, Treasury Targeting Sinaloa Cartel's Fentanyl Supply Chain
- What To Watch In High Court's FCA Scienter Standard Case
- Ex-Rep. Seeks Lenient Sentence For COVID Relief Schemes
- Ga. Needs To Resolve Cannabis Counsel Confusion
- 4th Circ. Backs UVA In Student Suit Alleging Anti-Swiss Bias
- McGinnis Lochridge Adds Ex-Nexsen Pruet Agribusiness Atty
- Health Hires: Generation Bio, Sunrider, Eiger
- Justice Alito Keeps US Access To Abortion Pill, For Now
- What To Know About 5th Circ.'s Midnight Abortion Pill Ruling
- Investors Fight For Class Cert. In Bayer Securities Fraud Suit
- Apple Exec Denies Hiring Cercacor CTO To Steal Watch Tech
- Alexion Investors Win Class Cert. Over Drug Sale Tactics
- Fla. Lawmakers Pass Bill Banning Abortions After 6 Weeks
- FTC Staff Say Full Pause Of Illumina Order Too Risky
- Medical Device Co. Calls Kickback Claim Nearly 'Sanctionable'
- Justices Told 'Billions' At Stake In AI Patent Crusade
- NC Families Push Again To Join Dow Asbestos Cancer Suits
- Fieldfisher Taps CBD Expert As Partner In London
- Now Is The Time For Independent Industry Self-Regulation
- FTC Warns Companies Not To Make Unbacked Health Claims
- Stockholders Partially Settle Bioverativ Suit In Del. For $84M
- AmEx Ruling Proves A Double-Edged Sword In Labor Antitrust
- Hartford Settles Ex-Salesman's Suit Over Disability Benefits
- McCarter & English Hires Baker Botts IP Expert In DC
- Covington Partner Must Testify Live In Zetia Trial, Judge Told
- 6th Circ. Says Scientist Must Pay $1M For Worthless Research
- DOJ To Take 5th Circ. Abortion Pill Ruling To Supreme Court
- Monster's Injunction Drops Bomb On Bang's 'Super Creatine'
- Merck, Glenmark Can Introduce 'Justifications' In Zetia Trial
- 5th Circ. Partly Stays Texas Judge's Abortion Pill Ruling
- US Tells Justices Ex-Interim USPTO Chief Had Review Power
- BioPharma Co. Escapes Investor Tumor Therapy Suit
- Investors Allege Caribou Oversold Cancer Therapy's Promise
- Abortion Pill Battle Puts Squeeze On Drug Benefit Managers
- Full 6th Circ. Urged To Revisit Circuit-Splitting FCA Hiring Case
- Danco Laboratories To Settle Marking Duties Suit For $765K
- Fed. Circ. Won't Revive Parkinson's Drug Patent
- 11th Circ. Vacates $8M Brain Supplement Deal
- Most Walmart Opioid Suit Claims Are Timely, Chancery Says
- Corcept Inks $14M Investor Deal Over Off-Label Drug Sales
- Fed. Circ. Breathes New Life Into IP Suit Against Philip Morris
- LifePoint Health Hit With OT Suit Over Kronos Hack
- Novartis Files Suit To Stop Chinese Entresto Generic
- Endo Gets OK For $27M Deal With Novavax In Contract Fight
- HHS Pitches Rule To Beef Up Abortion Privacy Protections
- More Indictments Possible In Merck Insider Case, Judge Told
- Do Videoconferences Establish Jurisdiction With Defendants?
- Juul To Pay $462M To End Predatory Marketing Claims
- Insys Founder Is No Threat, But May Not Get Early Release
- Starbucks Names Ex-Pfizer, Medtronic Atty As GC
- Apple Exec Voiced Concern About Sensor Efforts, Jury Hears
- Standing May Prove To Be Abortion Pill Ruling's Achilles' Heel
- Purdue Loses Case To Stop Generic OxyContin
- 240 Lawmakers See 'Imminent Harm' From Mifepristone Order
- Latham, Akin Attys Sank DNA Patent Row, Suit Says
- J&J Unit Ch. 11 Judge Slows Pace On Renewed Dismissal Try
- Elizabeth Holmes Can't Stay Free During Appeal, Judge Rules
- GSK Slams SG's Call To Tackle Skinny Labels At High Court
- Pharma Cos. Launch 2nd Gout Antitrust Case Against Takeda
- Generative AI Brings A New Generation Of Legal Issues
- Mallinckrodt Wants Out Of Manhattan Project Waste Suit
- Moderna Gets Fed. Circ. To Affirm Ax Of MRNA Patent
- Mich. County, Atty Sanctioned For Opioid Deal Challenge
- Allergan To Get Bulk Of $39M Drug Patent Win Over Sandoz
- EPA Floats New Ethylene Oxide Controls For Sterilizers
- AG's Cannabis Remarks Incongruous With Scheduling Review
- Humanism Should Replace Formalism In The Courts
- Viatris Wants To Rein In Neurim's Melatonin Patent Damages
- Outcome Health Execs Convicted Of Fraud
- Blackstone Wraps Up Record $30B Real Estate Fund
- DOJ Asks 5th Circ. To End 'Misguided' Abortion Pill Order
- Tivity Seeks Quick Win In Investors' Nutrisystem Buy Suit
- Masimo Exec Testifies To Secrecy Steps In $3B Apple Trial
- Feds Say ERISA, Medicare Preempt Part Of Okla. PBM Law
- Talc Claimants Call J&J Unit's New Ch. 11 Fraudulent
- Judge Says J&J Removed Hip Implant Suit To Cause Delay
- Navajo Hospital Wants $21M For Alleged IHS Contract Breach
- Dems Question SVB Depositors On Bank's 'Backscratching'
- NYC Man Admits Insider Trading On Merck Merger Secrets
- Online Lens Reseller Tries To Slide Out Of TM Fight Again
- W.Va. Strikes $7.9M Juul Deal Over Youth Marketing
- Pharma Execs Slam Abortion Pill Ruling, Citing Industry Risk
- CVS Wants HIV Patients' Disability Bias Suit Tossed
- Catching Up With Delaware's Chancery Court
- Masimo Co-Founder Hazy On Co.'s Claims In $3.1B Apple Suit
- J&J's New Talc Ch. 11 A Rehash Of Nixed Case, Claimants Say
- Texas Judge Pushes Pause On FDA Abortion Drug Approval
- 'Critically Sensitive' Kickback Issue Hurtles Toward High Court
- Medical Software Venture Opens Del. Ch. 11 With $33M Debt
- High Court Told FCA Knowledge Standard Clearly Subjective
- 7th Circ. Sides With Northwestern In Ex-Lab Tech's FMLA Suit
- Expect Merger Enforcement To Roll Full Steam Ahead
- Balwani Can't Dodge Prison Pending Appeal, 9th Circ. Says
- Catalyst Investors Ask Chancery To Pause Asia Purchase Vote
- IPO Prospects Seek Calm After Turbulent Start To 2023
- Insys Ch. 11 Trustee Slams Kapoor's Legal Fee Clawback Bid
- Del. Judge Certifies Appeal In Amgen, Teva Sensipar Case
- J&J Unit's Rival Loses Bid To Arbitrate Trade Secret Claims
- Masimo Execs Testify Behind Closed Doors In $3B Apple Trial
- Feds Want Prison For Trader In BigLaw Info Theft Case
- Fed. Circ. Roundup: PTAB Upheld, NeoMagic's Fee Bid Denied
- EPA Floats Cutting Ethylene Oxide, Other Chemical Emissions
- IP Forecast: Del. Judge Set To Turn Up Heat In Funding Probes
- FDA Revokes Clearance For Premature Birth Drug Makena
- Purdue Seeking OK To Put Over-The-Counter Biz Up For Sale
- Key Guidelines For Conducting Clinical Trials Overseas
- USPTO Says Revival Of Fintiv Suit Doesn't Help AstraZeneca
- Davis Graham Loses Patent Attorney To Kutak Rock
- Bristol-Myers, Dana-Farber Settle Cancer IP Dispute
- Doctor Tells 11th Circ. EPA Doesn't Bar Roundup Warning Suit
- Don't Let Client Demands Erode Law Firm Autonomy
- Distressed Cannabis Cos. Have A Few Options, With Caveats
- J&J Talc Plaintiffs Say Future Claims Rep Went Too Far
- COVID Fund Scammer To Appeal 8-Year Sentence
- Verily Life Sciences GC Joins Legal Defense Fund Board
- Outcome Health's Execs Knew Its Fraud The Best, Jury Hears
- Masimo Wants $3B From Apple Over Smartwatch IP, Jury Told
- Canine Implant Patent Fight Settles After J&J's $60M Trial Win
- Illumina To Appeal FTC's Grail Unwinding To 5th Circ.
- 4th Circ. Punts Pelvic Mesh Case Question To W.Va. Justices
- Health Groups Tell 5th Circ. FDA Right To Deny Vape Products
- Icahn Calls For Illumina CEO's Ouster Amid Its Battle With FTC
- Christian Clinic Seeks Review Of Axed Religious Bias Suit
- Texas Lab Inks $5.9M To Settle Kickback Allegations
- 6th Circ. Ruling's Seismic Shift In FCA Kickback Causation
- Why Event-Driven Securities Class Actions Often Succeed
- Arranta Prevails In Del. Noncompete Suit Filed By PSG
- Ex-Novartis VP, Former Prosecutor Joins Mandelbaum Barrett
- Medical Device Execs Buried Lead Test Defects, Feds Say
- Pfizer, Others Escape Patient Assistance RICO Suit, For Now
- Keep Your Apple Watches At Home, Judge Tells Masimo IP Jury
- Ex-Amarin CEO Says Hostile Takeover Cost Him His Job
- Skadden Adds Former Co-Head Of Proskauer's Trial Practice
- THC False Ad Plaintiffs Want Atty Fee Bid Tossed
- Jazz Overcharged For Narcolepsy Drug, Suit Alleges
- Dem AGs Support Rolling Back ACA Birth Control Exemption
- 5th Circ. Revives Biotech Co. Trade Secrets Suit Against Exec
- Lucira Stock Sale Not Blocked By Ch. 11 Stay, Judge Says
- Pfizer Draws Patent Suit Over COVID Vaccine
- 2 EU Laws Could Supercharge Product Liability Class Actions
- Gilead, DOJ Allowed To Redact Remaining Docs In Patent Row
- J&J Talc Unit Refiles For Ch. 11 With $8.9B Deal
- House Introduces Bill To Let Vets Access Medical Pot
- The Implications Of Moderna's Vaccine IP Defense Strategy
- Provention Investor Sues To Stop $2.9B Sanofi Merger
- 9th Circ. Says Insurer Can Recoup $2M Stem Cell Injury Outlay
- Cardinal Health Cuts $109M Deal In Suit Over J&J Unit Buy
- Ignore Big Pharma's Faux 'Facts,' HHS Says In Kickback Clash
- Nursing Home Co. Can't Shed 'Worthless Services' FCA Suit
- Chancery Rules Merck Kept Talc Liabilities In $14B Merger
- Judge Won't Triple PureWick's $28M Catheter Patent Win
- Texas Gets Win Over Head Start Vax Mandates
- Medtronic Wants 'Untenable' Insulin Pump Stock Suit Tossed
- Sentence For Conn. COVID Fraud Soars Above Guidelines
- Humana Sues Pharma Cos. Over Antipsychotic Generic Deal
- Catching Up With Delaware's Chancery Court
- Federal Judge's Amici Invitation Is A Good Idea, With Caveats
- FTC Orders Illumina To Unwind Grail Deal